A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia

Size: px
Start display at page:

Download "A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia"

Transcription

1 OMIM # FULL NAME A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia phenylketonuria due to PTPS deficiency phenylketonuria due to DHPR deficiency phenylketonuria due to PCD deficiency DOPA-responsive dystonia (TH, SPR, GCH1) leucinose, maple syrup urine disease (MSUD) tyrosinemia type tyrosinemia type tyrosinemia type alkaptonuria homocystinuria, B6 responsive and non responsive homocystinuria due to MTHFR deficiency homocystinuria-megaloblastic anemia Cbl E & G type methionine S-adenosyltransferase deficiency glycine N-methyltransferase deficiency S-adenosylhomocystine hydrolase deficiency hyperammonemia due to CPS deficiency hyperammonemia due to OTC deficiency citrullinemia type I citrullinemia type II argininosuccinic aciduria (ASL deficiency) argininemia (arginase deficiency) hyperammonemia due to NAGS deficiency hyperornithinemia, hyperammonemia, homocitrullinuria (HHH) lysinuric protein intolerance gyrate atrophy, B6 responsive or non responsive hyperlysinemia (alpha-aminoadipic semialdehyde synthase deficiency) non ketotic hyperglycinaemia hartnup disorder Disorders of serine metabolism Disorders of proline/hydroxyproline/pyrroline carboxylate metabolism hypotonia-cystinuria Lowe oculocerebral syndrome B. organic acidemias methylmalonic aciduria (CblA,B,C,D,F) methylmalonic aciduria mutase deficiency type

2 transcobalamin 2 deficiency propionic acidemia isovaleric aciduria methylcrotonylglycinuria methylglutaconic aciduria type 1, 2, 3, 4, HMG CoA lyase deficiency glutaric aciduria type glutaric aciduria type 2 (MADD) L-2 and D-2-OH glutaric aciduria hydroxybutyric aciduria (SSADH deficiency) isobutyryl CoA dehydrogenase deficiency (ACAD8) short/branched chain acylcoa dehydrogenase deficiency (SBCADD) malonic aciduria C. biotin-responsive disorders holocarboxylase synthase deficiency biotinidase deficiency biotin responsive basal ganglia disease D. disorders of carbohydrate metabolism and glycogen storage diseases sucrase isomaltase deficiency congenital glucose/galactose malabsorption hereditary fructose intolerance galactosemia (uridylyltransferase deficiency) galactosemia (epimerase deficiency) galactosemia (galactokinase deficiency) transaldolase deficiency pyruvate carboxylase deficiency phosphoenolpyruvate carboxykinase (PEPCK) deficiency fructose 1,6-bisphosphatase deficiency glycogenose 0 (glycogen synthase deficiency) glycogenose Ia and Ib (G6Pase) glycogenose 3 Cori glycogenose 4 Andersen glycogenose 5 Mc Ardle glycogenose 6 Hers glycogenose 7 Tarui glycogenose IX phosphorylase kinase glycogenosis X (phosphoglycerate mutase deficiency) phosphoglycerate kinase deficiency

3 lactate dehydrogenase deficiency (type XI) aldolase A deficiency (type XII) β-enolase deficiency (type XIII) glucose transporter defect De Vivo syndrome (GLUT-1) fanconi-bickel syndrome (GLUT-2) E. hyperinsulinism hyperinsulinism-hyperammonemia syndrome (HiHa) and familial hyperinsulinemic hypoglycemia, types 1-7 F. disorders of mitochondrial energy metabolism pyruvate dehydrogenase deficiency mitochondrial complex I deficiency mitochondrial complex II deficiency mitochondrial complex III deficiency mitochondrial complex IV deficiency mitochondrial complex V deficiency and mitochondrial DNA mutation/deletion/elongation and nuclear DNA mutation affecting mitochondrial structure and/or function and mitochondrial DNA depletion syndrome clinical syndrome associated with mitochondrial disorder and (report+board advise) and krebs cycle enzyme deficiencies coq10 synthesis defects G. mitochondrial beta oxidation defects camitine transporter deficiency camitine palmitoyltransferase 1 deficiency camitine translocase camitine palmitoyltransferase 2 deficiency short chain acyl coa dehydrogenase deficiency (SCADD) short chain 3 oh acyl coa dehydrogenase deficiency (SCHADD) medium chain acyl coa dehydrogenase deficiency (MCADD) long chain acyl coa dehydrogenase deficiency (LCADD) long chain 3 oh acyl coa dehydrogenase deficiency (LCHADD) very long chain acyl coa dehydrogenase deficiency (VLCADD) mitochondrial trifunctional protein

4 H. disorders of ketone body metabolism hydroxy-3-methylglutaryl-coA synthase deficiency hydroxy-3methylglutaryl-coA lyase deficiency succinyl-coa 3-oxoacid coa transferase deficiency (scot) β-ketothiolase deficiency I. disorders of sterol, bile acid, lipid and lipoprotein metabolism smith-lemli-opitz syndrome mevalonic aciduria β-hydroxy δ5 c27 hydroxysteroid dehydrogenase deficiency α methylacyl-coa racemase deficiency δ4-3-oxosteroid 5β reductase deficiency oxysterol 7α hydroxylase deficiency cerebrotendinous xanthomatosis familial lipoprotein lipase deficiency & apo c2 deficiency Abetalipoproteinemia Tangier disease and Inborn hypertriglyceridemia and lipodystrophy syndromes LCAT-deficiency (Norum disease and Fish-eye disease) Hypo-alphalipoproteinemia LPIN1 lipid myopathy Wolman & cholesteryl ester storage disease J. peroxisomal disorders zellweger spectrum (peroxisome biogenesis defects) acyl-coa oxidase deficiency D-bifunctional protein deficiency methyl-CoA racemase deficiency X-linked adrenoleukodystrophy Rhizomelic chondrodysplasia punctata Refsum disease Refsum disease infantile form K. lysosomal disorders glycogen storage disease type 2 (Pompe) glycogen storage disease type 2b (Danon and PRK- AG2) Gaucher disease, type I, II and III Fabry disease Hurler-Scheie disease (MPS I)

5 Hunter disease (MPS II) Sanfilippo A; B; C; D (MPS III) MPS types (IV, V, VI, VII, VIII) Niemann-Pick type A and B Niemann-Pick type C and GM1 and GM2 gangliosidosis Metachromatic Leukodystrophy Krabbe leukodystrophy Mannosidosis Sialidosis and galactosialidosis I-cell disease and mucolipidosis II/III Free sialic storage diseases Mucolipidosis IV Fucosidosis multiple sulfatase deficiency Farber lipogranulomatosis and ceroid lipofuscinosis type 1-10 L. disorders of purine and pyrimidine metabolism phosphoribosyl pyrophosphate synthetase superactivity adenylosuccinate lyase deficiency xanthinuria Lesch-Nyhan syndrome M. disorders of creatine metabolism guanidinoacetate methyltransferase deficiency (GAMT) arginine:glycine amidinotransferase deficiency (AGAT) creatine transporter deficiency N. disorders of neurotransmitter and small peptide metabolism and γ-glutamyl transpeptidase deficiency and disorders of glutathion metabolism folate transporter defects trimethylaminuria & dimethylglycine dehydrogenase deficiency aromatic amino-acid decarboxylase (AADC) gaba transaminase deficiency monoamine oxidase deficiency dopamine beta-hydroxylase deficiency pyridoxine dependent seizures pyridoxamine 5-phosphate oxidase deficiency (pyri-

6 doxal-p responsive seizures) molybdenum cofactor deficiency, sulfite oxidase deficiency acetylaspartic aciduria (Canavan s disease) O. Congenital defects of glycosylation (CDG) and Congenital disorders of N- and/or O-glycosylation P. porphyrias aminolevulinic acid synthase deficiency aminolevulinic acid dehydratase porphyria acute intermittent porphyria hereditary coproporphyria variegate prophyria congenital erythropoietic porphyria erythropoietic protoporphyria Q. disorders of copper metabolism menkes disease Wilson disease R. progressive neurodegenerative diseases Alexander disease (GFAP) Infantile neuroaxonal dystrophy (PLA2G6) Vanishing white matter disease Pelizaeus-Merzbacher disease S. connective tissue disorders and osteogenesis imperfecta

Diagnose a broad range of metabolic disorders with a single test, Global MAPS

Diagnose a broad range of metabolic disorders with a single test, Global MAPS PEDIATRIC Assessing or diagnosing a metabolic disorder commonly requires several tests. Global Metabolomic Assisted Pathway Screen, commonly known as Global MAPS, is a unifying test for analyzing hundreds

More information

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the Walkthrough of IEMbase When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the disclaimer, users are directed to the main page, which presents a search

More information

All diseases on Foresight

All diseases on Foresight All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency

More information

CHRONIC MYELOGENOUS LEUKEMIA

CHRONIC MYELOGENOUS LEUKEMIA CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases

More information

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.

More information

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Coincide nce Expected coincidence Maximum possible comorbidity Disease1 Disease2 Link(KEGG)

More information

Further expansion of the neonatal screening panel in the Netherlands

Further expansion of the neonatal screening panel in the Netherlands Further expansion of the neonatal screening panel in the Netherlands J.Gerard Loeber APHL-NBSGT, St.Louis (MO), USA 290216 Population Area Newborns 6.01 million 0.35:1 16.8 million 180,693 sq km 4.3:1

More information

COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS

COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS S MELDAU, G VAN DER WATT INHERITED METABOLIC DISEASES GROUP UCT /

More information

For Your Baby s Health Department of Health

For Your Baby s Health Department of Health Newborn Screening For Your Baby s Health Department of Health Why is my baby tested? To help make sure your baby will be as healthy as possible. The blood test provides important information about your

More information

National Metabolic Biochemistry Network Best Practice Guidelines. The Biochemical Investigation of Fits and Seizures for Inherited Metabolic Disorders

National Metabolic Biochemistry Network Best Practice Guidelines. The Biochemical Investigation of Fits and Seizures for Inherited Metabolic Disorders Introduction National Metabolic Biochemistry Network Best Practice Guidelines The Biochemical Investigation of Fits and Seizures for Inherited Metabolic Disorders These guidelines describe the differential

More information

Approach to diagnosis of metabolic diseases

Approach to diagnosis of metabolic diseases Translational Science of Rare Diseases 1 (2016) 3 22 DOI 10.3233/TRD-160001 IOS Press 3 Approach to diagnosis of metabolic diseases Enid Gilbert-Barness a,b and Philip M. Farrell c,d, a Department of Pathology,

More information

Disorders Disorder No.

Disorders Disorder No. Part Three Indices Index A Abetalipoproteinemia 28.9 Aceruloplasminemia 33.6 a-n-acetylgalactosamine 4-sulfatase deficiency 18.9 Acetyl CoA: a-glucosaminide N-acetyltransferase deficiency 18.5 Acid maltase

More information

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES NEWBORN SCREENING Protecting your newborn MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES [ 1 ] NEWBORN SCREENING [ 2 ] FREQUENTLY ASKED QUESTIONS [ 4 ] DISORDERS INCLUDED IN NEWBORN SCREENING [ 12 ]

More information

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Metabolic birth defects can cause physical problems, mental retardation and, in some cases, death. It is

More information

Current Management and Future Developments in Metabolic Disease

Current Management and Future Developments in Metabolic Disease Current Management and Future Developments in Metabolic Disease APAGBI Annual Scientific Meeting Friday 15 th May 2015 Dr Saikat Santra Birmingham Children s Hospital, UK Outline Metabolic disorders in

More information

Beyond the case for NBS in South Africa. Chris Vorster 28/05/2016

Beyond the case for NBS in South Africa. Chris Vorster 28/05/2016 Beyond the case for NBS in South Africa Chris Vorster 28/05/2016 The case for NBS in SA Economic justification Cost Utility analysis = Cost/QALY GDP/Capita Immediate implementation (WHO) Political justification

More information

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE: MEDICAL FOODS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are

More information

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES NEWBORN SCREENING health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES Table of Contents NEWBORN SCREENING...1 FREQUENTLY ASKED QUESTIONS...2 DISORDERS INCLUDED IN NEWBORN SCREENING...4

More information

N.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017

N.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017 Tests and Profiles Tests Method Sample Needed TAT Genetic Consultation / - All samples to be sent at 2 8 C. Counseling 1 Urine MRST - 15 ml Urine 24 hrs 2 Sr. Ammonia, Lactate, Sugar Fuji Dry Chem 2 ml

More information

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Newborn Screening Examination parameters: TSH-neonatal (hypothyreosis), 17-OH progesterone (AGS), galactose (galactosemia), galactose-uridyl transferase (galacto semia), biotinidase (biotinidase ), phenylalanine

More information

CLINICAL AND HUMAN TESTING

CLINICAL AND HUMAN TESTING CLINICAL AND HUMAN TESTING CARRIER SCREENING FOR FAMILY PLANNING Let knowledge be your guide. Identify genetic conditions before or during a pregnancy to help predict the chances of having a child with

More information

Summary. Syndromic versus Etiologic. Definitions. Why does it matter? ASD=autism

Summary. Syndromic versus Etiologic. Definitions. Why does it matter? ASD=autism Summary It is becoming clear that multiple genes with complex interactions underlie autism spectrum (ASD). A small subset of people with ASD, however, actually suffer from rare single-gene Important to

More information

Inborn Errors of Metabolism (IEM) An Indian Perspective

Inborn Errors of Metabolism (IEM) An Indian Perspective Symposium on Fest - Schrift for Late Dr. P.M. Udani Inborn Errors of Metabolism (IEM) An Indian Perspective N.B. Kumta Department of Pediatrics, KEM Hospital, Mumbai, Maharashtra, India. Abstract. The

More information

PREDICAGEN LLC REPORT

PREDICAGEN LLC REPORT The report below is a scientific interpretation of the DNA variants (referred as RS numbers) to the customer by a third party (for example 23andMe). The report should not be considered exclusive, because

More information

INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides

INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides INBORN ERRORS OF METABOLISM (IEM) 1 OBJECTIVES What are IEMs? Categories When to suspect? History and clinical pointers Metabolic presentation Differential diagnosis Emergency and long term management

More information

The spectrum and outcome of the. neonates with inborn errors of. metabolism at a tertiary care hospital

The spectrum and outcome of the. neonates with inborn errors of. metabolism at a tertiary care hospital The spectrum and outcome of the neonates with inborn errors of metabolism at a tertiary care hospital Dr. Sevim Ünal Neonatology Division, Ankara Children s Hematology Oncology Research Hospital, Ankara,

More information

Metabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius

Metabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius Metabolic Changes in ASD Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius 12 patients 3 Autism: Ages 3/3/3.7 3 PDD: Ages 3/3/6 3 Asperger: Ages 6/7/15.1 3 Speech delay and Sensory Problems (SHL):

More information

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up Dr. Josephine Chong Clinical Professional Consultant Centre of Inborn Errors

More information

Paediatric Inherited Metabolic Medicine

Paediatric Inherited Metabolic Medicine RCPCH Progress Paediatric curriculum for excellence Paediatric Inherited Metabolic Medicine Level 3 Paediatrics Sub-specialty Syllabus Version 1 Approved by the GMC for implementation from 1st August 2018

More information

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Answers for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation

More information

Training Syllabus CLINICAL SYLLABUS

Training Syllabus CLINICAL SYLLABUS Training Syllabus CLINICAL SYLLABUS SYLLABUS FOR TRAINING IN CLINICAL PAEDIATRIC METABOLIC MEDICINE Updated July 2006 This syllabus is intended as a guide. Whilst the training should be comprehensive,

More information

Doenças Hereditárias do Metabolismo: de Garrod às Ciências Ómicas

Doenças Hereditárias do Metabolismo: de Garrod às Ciências Ómicas Doenças Hereditárias do Metabolismo: de Garrod às Ciências Ómicas Isabel Tavares de Almeida Lab. Met & Gen. FFULisboa XIII Curso Básico de Doenças Hereditárias do Metabolismo Coimbra, 5 a 7 Dezembro 2016

More information

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of

More information

Clinical Approach to Diagnosis of Lysosomal Storage Diseases

Clinical Approach to Diagnosis of Lysosomal Storage Diseases Clinical Approach to Diagnosis of Lysosomal Storage Diseases M. Rohrbach, MD, PhD FMH Pädiatrie und FMH Medizinische Genetik Abteilung Stoffwechsel Universitätskinderklinik Zürich Lysosomal storage disorders

More information

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Information for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation

More information

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995 RULES AND REGULATIONS PERTAINING TO THE NEWBORN METABOLIC, ENDOCRINE, AND HEMOGLOBINOPATHY SCREENING PROGRAM AND THE NEWBORN HEARING LOSS SCREENING PROGRAM [R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE

More information

Inborn Errors of Metabolism (IEM)

Inborn Errors of Metabolism (IEM) Clinical Presentation Inborn Errors of Metabolism (IEM) Click on the following: - Clinical Pearl - link to movie clip - link to picture Investigations Blood Work Urine No Acidosis NH 4 + Metabolic Acidosis

More information

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018 Neurodegenerative disorders: an approach to investigation Robert Robinson Practical Paediatric Neurology Study Days April 2018 Aims An approach to investigating and diagnosing young children with progressive

More information

Metabolic Disorders. Chapter Thomson - Wadsworth

Metabolic Disorders. Chapter Thomson - Wadsworth Metabolic Disorders Chapter 28 1 Metabolic Disorders Inborn errors of metabolism group of diseases that affect a wide variety of metabolic processes; defective processing or transport of amino acids, fatty

More information

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population carrier screening program Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population 2015 8,134,500 inhabitants Jews (75.1%) Ashkenazi, non

More information

Childhood epilepsy: the biochemical epilepsies. Dr Colin D Ferrie Consultant Paediatric Neurologist Leeds General Infirmary

Childhood epilepsy: the biochemical epilepsies. Dr Colin D Ferrie Consultant Paediatric Neurologist Leeds General Infirmary Childhood epilepsy: the biochemical epilepsies Dr Colin D Ferrie Consultant Paediatric Neurologist Leeds General Infirmary Definitions Epileptic Seizure Manifestation(s) of epileptic (excessive and/or

More information

Newborn Screening: Focus on Treatment

Newborn Screening: Focus on Treatment Newborn Screening: Focus on Treatment Alan R. Fleischman, M.D. Senior Vice President and Medical Director March of Dimes National Conference of State Legislatures July 21, 2008 Newborn Screening: A Public

More information

METABOLISM OF AMINO ACIDS

METABOLISM OF AMINO ACIDS Dr. M. Sasvari METABOLISM OF AMINO ACIDS 2. The fate of the carbon sceleton 3 N + C R Active C 1 intermediers The folate derivatives structure s Folate (F) - vitamin Folate, 2 F, 4 F Dihydrofolate ( 2

More information

Considerations in Choosing Screening Conditions: One (US) Approach

Considerations in Choosing Screening Conditions: One (US) Approach 22 Plenary Considerations in Choosing Screening Conditions: One (US) Approach Bradford L Therrell Jr, 1,2 MS, PhD Abstract The lack of a national policy on newborn screening (NBS) in the United States

More information

Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet

Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet Website:www.tipn.org.tw Telephone:(02)85962050 Ext. 401-403 Service line:(02)85962065 Fax:(02)85962067

More information

SYLLABUS FOR TRAINING IN CLINICAL PAEDIATRIC METABOLIC MEDICINE

SYLLABUS FOR TRAINING IN CLINICAL PAEDIATRIC METABOLIC MEDICINE SYLLABUS FOR TRAINING IN CLINICAL PAEDIATRIC METABOLIC MEDICINE Updated December 2014: Vassili Valayannopoulos and Andrew Morris Paediatrics is an independent medical specialty based on the knowledge and

More information

Dysmorphology Guy Besley

Dysmorphology Guy Besley Dysmorphology Guy Besley Willink Biochemical Genetics Unit, Manchester Children s s Hospital Dysmorphic presentation Congenital malformation Disorder of embryogenesis Intrauterine insult infection; chromosomal/genetic

More information

Positive Newborn Screens: What do you do next?

Positive Newborn Screens: What do you do next? Positive Newborn Screens: What do you do next? James B. Gibson, MD, Ph.D. Biochemical Geneticist at Specially for Children Clinical Associate Professor of Pediatrics UTHSCSA Carla R. Scott, MD Pediatric

More information

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen Metabolic Disorders ed Overseas but not ed in Australia Biotinidase Deficiency Severe form causes seizures & delay Biotin can prevent complications NZ, USA Tyrosinaemia Type I Coma & death before age 10

More information

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Alan R. Fleischman, M.D. Senior Vice President and Medical Director Chair, Federal Advisory Committee,

More information

Medical Foods for Inborn Errors of Metabolism

Medical Foods for Inborn Errors of Metabolism Medical Foods for Inborn Errors of Metabolism Policy Number: Original Effective Date: MM.02.014 02/18/2000 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 08/23/2013 Section: Medicine Place(s)

More information

By: Dr Hadi Mozafari 1

By: Dr Hadi Mozafari 1 By: Dr Hadi Mozafari 1 Gluconeogenesis is the process of converting noncarbohydrate precursors to glucose or glycogen. The major substrates are the glucogenic amino acids, and lactate, glycerol, and propionate.

More information

CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE. Bwee Tien Poll-The Amsterdam UMC The Netherlands

CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE. Bwee Tien Poll-The Amsterdam UMC The Netherlands CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE Bwee Tien Poll-The Amsterdam UMC The Netherlands FRAMEWORK OF PRINCIPALS 1. Problem-oriented clinical approach 2. Biomarkers in plasma, urine, CSF

More information

CarrierMap. Genetic Counseling. Technology TABLE OF. Sample Report CONTENTS. New Offerings. Recombine Facts. Disease List

CarrierMap. Genetic Counseling. Technology TABLE OF. Sample Report CONTENTS. New Offerings. Recombine Facts. Disease List Recombine 2 CarrierMap 4 Genetic Counseling TABLE OF CONTENTS 8 12 14 Technology Sample Report New Offerings 18 Recombine Facts 19 Disease List CARRIERMA ROVIDES COMLETE We help families have healthy children

More information

CSF Investigations in patients with seizures. Dr Simon Olpin Sheffield Children s Hospital

CSF Investigations in patients with seizures. Dr Simon Olpin Sheffield Children s Hospital CSF Investigations in patients with seizures Dr Simon Olpin Sheffield Children s Hospital Background Epileptic seizures common feature in many inherited metabolic disorders particularly those involving

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4

More information

CARRIER SCREEN - LIST OF DISORDERS

CARRIER SCREEN - LIST OF DISORDERS 1 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 2 17-Beta-Hydroxysteroid deyhdrogenase X deficiency 3 2-Methylbutytyrglycinuria 4 21-hydroxylase deficiency 5 3-Methylcrotonyl-CoA carboxylase

More information

inborn errors of metabolism biochemical basis

inborn errors of metabolism biochemical basis inborn errors of metabolism biochemical basis What is an inborn error of metabolism (IEM)? Genetically determined biochemical disorders, that affect an individual s ability to convert nutrients or to use

More information

A Guide for Prenatal Educators

A Guide for Prenatal Educators A Guide for Prenatal Educators Why Teach Newborn Screening This booklet is designed to make it easy for you, a prenatal educator, to effectively inform expectant parents about newborn screening. All of

More information

EURORDIS Member Organisations - Diseases - ERN Groupings Working Document

EURORDIS Member Organisations - Diseases - ERN Groupings Working Document EURORDIS Member Organisations - Diseases - ERN Groupings Working Document Diseases ERN Group - Primary ERN Group - secondary Achondroplasia Fibrodysplasia ossificans progressiva Fibrous dysplasia of bone

More information

Testing Strategy for Inborn Errors of Metabolism in the Neonate Aditi I. Dagli, Roberto T. Zori and Bryce A. Heese. DOI: /neo.

Testing Strategy for Inborn Errors of Metabolism in the Neonate Aditi I. Dagli, Roberto T. Zori and Bryce A. Heese. DOI: /neo. Testing Strategy for Inborn Errors of Metabolism in the Neonate Aditi I. Dagli, Roberto T. Zori and Bryce A. Heese Neoreviews 2008;9;e291 DOI: 10.1542/neo.9-7-e291 The online version of this article, along

More information

Antenatal diagnosis of inborn errors of metabolism

Antenatal diagnosis of inborn errors of metabolism 816 Archives ofdisease in Childhood 199 1; 66: 816-822 CURRENT PRACTICE Willink Biochemical Genetics Unit, Royal Manchester Children's Hospital, Pendlebury Manchester M27 IHA M A Cleary J E Wraith Correspondence

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:

More information

GUIDE TO NEWBORN SCREENING PROGRAMME

GUIDE TO NEWBORN SCREENING PROGRAMME \ GUIDE TO NEWBORN SCREENING PROGRAMME 1 MEDILAB PROFILE MEDILAB, the leading independent provider of Clinical Laboratory Diagnostic Services in Cyprus, was established in 1980 by Mr. C. Pavlides and has

More information

Newborn bloodspot testing

Newborn bloodspot testing Policy HUMAN GENETICS SOCIETY OF AUSTRALASIA ARBN. 076 130 937 (Incorporated Under the Associations Incorporation Act) The liability of members is limited RACP, 145 Macquarie Street, Sydney NSW 2000, Australia

More information

BIOTIN (BIOTINIDASE) DEFICIENCY Marc E. Tischler, PhD; University of Arizona

BIOTIN (BIOTINIDASE) DEFICIENCY Marc E. Tischler, PhD; University of Arizona BIOTIN (BIOTINIDASE) DEFICIENCY Marc E. Tischler, PhD; University of Arizona BIOTIN (BIOTINIDASE) DEFICIENCY biotin in the body is recycled by its removal from carboxylase enzymes to which it is attached

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 06/23/2017 Date Received: 06/28/2017 Date Tested: 06/28/2017 Indication:

More information

Amino acid metabolism I

Amino acid metabolism I Amino acid metabolism I Jana Novotná Department of the Medical Chemistry and Clinical Biochemistry The 2nd Faculty of Medicine, Charles Univ. Metabolic relationship of amino acids DIETARY PROTEINS GLYCOLYSIS

More information

Urea Cycle Disorders and Hyperammonemia: Diagnosable Treatable Screenable

Urea Cycle Disorders and Hyperammonemia: Diagnosable Treatable Screenable Urea Cycle Disorders and Hyperammonemia: Diagnosable Treatable Screenable Marshall L. Summar, M.D. Chief, Division of Genetics and Metabolism Children s National Medical Center Washington, DC, USA Disclosure

More information

Points 1. Following is the overall reaction catalyzed by the Calvin-Benson cycle:

Points 1. Following is the overall reaction catalyzed by the Calvin-Benson cycle: BCH 4054 February 22, 2002 HOUR TEST 2 NAME_ Points 1. Following is the overall reaction catalyzed by the Calvin-Benson cycle: CO 2 + 3ATP + 2NADPH 1/3 glyceraldehyde-3-p + 3ADP + 2NADP + Give the structures

More information

OVERVIEW M ET AB OL IS M OF FR EE FA TT Y AC ID S

OVERVIEW M ET AB OL IS M OF FR EE FA TT Y AC ID S LIPOLYSIS LIPOLYSIS OVERVIEW CATABOLISM OF FREE FATTY ACIDS Nonesterified fatty acids Source:- (a) breakdown of TAG in adipose tissue (b) action of Lipoprotein lipase on plasma TAG Combined with Albumin

More information

TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN

TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN Susan Tanksley, PhD May 19, 2015 TIMELINESS - BACKGROUND In order to effectively

More information

Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism

Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism Patricia Jones, PhD DABCC FACB UT Southwestern Medical Center Children s Medical Center Dallas, Texas Learning Objectives Justify

More information

Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD

Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD April 24, 2017 SAP 2017 Buenos Aires Genetic disorders are rare why

More information

Neonatal Guidelines. Chapter 10: Metabolic V Date Revised : January 2017 Ratified 6 th February Date for Review: 1 st of March 2021

Neonatal Guidelines. Chapter 10: Metabolic V Date Revised : January 2017 Ratified 6 th February Date for Review: 1 st of March 2021 Neonatal Guidelines Chapter 10: Metabolic V2017.1 Specialty: Neonatal Medicine Revised by: Jean Matthes Date Revised : January 2017 Ratified 6 th February 2017 Approved by: ABMU Joint Perinatal Forum Date

More information

(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;

(f) Birthing center means any facility that is licensed by the Georgia Department of Community Health as a birthing center; Ga. Comp. R. & Regs. r. 511-5-5-.02 Definitions Rule 511-5-5-.02. Definitions (a) "Abnormal test result" is a test result from blood testing or physiologic monitoring that is outside the screening limits

More information

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics SESSION 7 Medical Genetics Hemoglobinopathies and Biochemical Genetics J a v a d F a s a J a m s h i d i U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 Hemoglobinopathies

More information

Title: Assessing Recommendations Related To Timeliness of Newborn Screening

Title: Assessing Recommendations Related To Timeliness of Newborn Screening Title: Assessing Recommendations Related To Timeliness of Newborn Screening Purpose: In January 2014, the Secretary s Discretionary Advisory Committee on Heritable Diseases on Newborns and Children (Committee)

More information

Newborn Screening: Blood Spot Disorders

Newborn Screening: Blood Spot Disorders Newborn Screening: Blood Spot Disorders Arizona s Newborn Screening Program Program Overview Panel of Disorders Disorder Descriptions Program Components Hospitals ADHS Lab ADHS Follow-up ADHS Billing Medical

More information

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions: NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status

More information

Syllabus for Training in Inborn Errors of Metabolism for Scientists and Medically Qualified Laboratory Staff

Syllabus for Training in Inborn Errors of Metabolism for Scientists and Medically Qualified Laboratory Staff Training Syllabus LABORATORY SYLLABUS Syllabus for Training in Inborn Errors of Metabolism for Scientists and Medically Qualified Laboratory Staff This syllabus is intended as a guide. Whilst the training

More information

Amino Acid Catabolism

Amino Acid Catabolism Amino Acid atabolism 3-1 Lec #8 To date we have considered the catabolism of carbohydrates and lipids with the object of generating energy in the form of ATP. Both give rise to AcoA which is fed through

More information

Newborn Screening in Manitoba. Information for Health Care Providers

Newborn Screening in Manitoba. Information for Health Care Providers Newborn Screening in Manitoba Information for Health Care Providers Newborn screening: a healthy start leads to a healthier life Health care professionals have provided newborn screening for phenylketonuria

More information

Subject: Enteral Formulas

Subject: Enteral Formulas 09-J0000-61 Original Effective Date: 07/15/02 Reviewed: 04/26/18 Revised: 11/15/18 Subject: Enteral Formulas THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION, EXPLANATION OF BENEFITS,

More information

Best Practice Guidelines for the Biochemical Investigation of Patients with Foetal and Neonatal Hydrops

Best Practice Guidelines for the Biochemical Investigation of Patients with Foetal and Neonatal Hydrops National Metabolic Biochemistry Network Best Practice Guidelines for the Biochemical Investigation of Patients with Foetal and Neonatal Hydrops INTRODUCTION Hydrops is defined as the presence of skin oedema

More information

Non-Lysosomal Glycogen Storage Disorders Biochemical Diagnosis

Non-Lysosomal Glycogen Storage Disorders Biochemical Diagnosis Non-Lysosomal Glycogen Storage Disorders Biochemical Diagnosis Katie Bainbridge Enzyme Laboratory Great Ormond Street Hospital Glycogen Metabolism Glycogen Glycogen -glucosidase Lysosome Brancher Glycogen

More information

Utility of Microarrays in Molecular Genetics

Utility of Microarrays in Molecular Genetics Utility of Microarrays in Molecular Genetics Madhuri Hegde, Ph.D., FACMG Associate Professor Senior Director Department of Human Genetics Emory Genetics Laboratory Emory University School of Medicine Atlanta,

More information

Suspected Metabolic Disease in the Newborn Period Acute Management "What do I do?" Barbara Marriage, PhD RD Abbott Nutrition

Suspected Metabolic Disease in the Newborn Period Acute Management What do I do? Barbara Marriage, PhD RD Abbott Nutrition Suspected Metabolic Disease in the Newborn Period Acute Management "What do I do?" Barbara Marriage, PhD RD Abbott Nutrition Introduction Review clinical findings that may be suspicious of a metabolic

More information

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) BULGARIAN NATIONAL PLAN FOR RARE DISEASES 2009 2013 Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) Strategy for rare diseases in Bulgaria Project of National

More information

TECHNICAL INFORMATION GUIDE

TECHNICAL INFORMATION GUIDE TECHNICAL INFORMATION GUIDE INHERITED METABOLIC DISORDERS TEST www.metabolon.com TEST SUMMARY Metabolomic profiling is a large-scale, semi-quantitative technology that provides a highly efficient small-molecule

More information

Inborn Errors of Metabolism. Metabolic Pathway. Digestion and Fasting. How is Expanded Newborn Screening Different? MS/MS. The body is a factory.

Inborn Errors of Metabolism. Metabolic Pathway. Digestion and Fasting. How is Expanded Newborn Screening Different? MS/MS. The body is a factory. Inborn Errors of Metabolism The body is a factory. Inborn errors of metabolism are rare genetic disorders in which the body cannot properly turn food into energy. The disorders are usually caused by defects

More information

devact TM Clinical Management Panel for Neurodevelopmental Disorders

devact TM Clinical Management Panel for Neurodevelopmental Disorders Amino acid disorder AMT Glycine encephalopathy (non-ketotic hyperglycinemia) Amino acid disorder GCSH Glycine encephalopathy (non-ketotic hyperglycinemia) Amino acid disorder GLDC Glycine encephalopathy

More information

Structure. Lysosomes are membrane-enclosed organelles. Hydrolytic enzymes. Variable in size & shape need

Structure. Lysosomes are membrane-enclosed organelles. Hydrolytic enzymes. Variable in size & shape need Lysosomes Structure Lysosomes are membrane-enclosed organelles Hydrolytic enzymes Variable in size & shape need Degrade material taken up from outside and inside the cell Variable in size and shape Lysosomal

More information

Catabolism of Carbon skeletons of Amino acids. Amino acid metabolism

Catabolism of Carbon skeletons of Amino acids. Amino acid metabolism Catabolism of Carbon skeletons of Amino acids Amino acid metabolism Carbon skeleton Carbon Skeleton a carbon skeleton is the internal structure of organic molecules. Carbon Arrangements The arrangement

More information

BIOCHEMICAL GENETICS UNIT METABOLIC ASSAYS

BIOCHEMICAL GENETICS UNIT METABOLIC ASSAYS BIOCHEMICAL GENETICS UNIT METABOLIC ASSAYS USERS HANDBOOK Version 5.0 PLEASE DO NOT USE AFTER JUNE 2011 BGU Handbook version 5.0 June 2010 1 CONTENTS CONTENTS 2 1 CONTACT DETAILS AND ENQUIRIES 3 2 GENERAL

More information

Inborn errors of metabolism causing epilepsy

Inborn errors of metabolism causing epilepsy DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY REVIEW Inborn errors of metabolism causing epilepsy SHAMIMA RAHMAN EMMA J FOOTITT SOPHIA VARADKAR PETER T CLAYTON Clinical and Molecular Genetics and Neurosciences

More information

number Done by Corrected by Doctor Nayef Karadsheh

number Done by Corrected by Doctor Nayef Karadsheh number 13 Done by Asma Karameh Corrected by Saad hayek Doctor Nayef Karadsheh Gluconeogenesis This lecture covers gluconeogenesis with aspects of: 1) Introduction to glucose distribution through tissues.

More information

USERS HANDBOOK Version 4.0

USERS HANDBOOK Version 4.0 USERS HANDBOOK Version 4.0 BIOCHEMICAL GENETICS UNIT ADDENBROOKE S HOSPITAL CAMBRIDGE PLEASE DO NOT USE AFTER JUNE 2010 CONTENTS CONTENTS 2 1 CONTACT DETAILS AND ENQUIRIES 4 2 GENERAL INFORMATION 5 3 SPECIMEN

More information

Acylcarnitines And Inherited Metabolic Disease. David Hardy

Acylcarnitines And Inherited Metabolic Disease. David Hardy Acylcarnitines And Inherited Metabolic Disease David Hardy Overview Free Carnitine and Acylcarnitines Role in fatty acid oxidation Appearance in disease Measurement by tandem MS Examples of use in diagnosis

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:

More information